Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy
P. Bai, Y. Li, Q. Zhou, J. Xia, P.-C. Wei, H. Deng, M. Wu, S. K. Chan, J. W. Kappler, Y. Zhou, E. Tran, P. Marrack, L. Yin
The paper classifies neoantigens based on immune interactions and improves their prioritization for cancer immunotherapy.
bioRxiv · Jan 27, 2021Cancer Biology